Amyloidotic cardiomyopathy: multidisciplinary approach to diagnosis and treatment.
Heart Fail Clin
; 7(3): 385-93, 2011 Jul.
Article
en En
| MEDLINE
| ID: mdl-21749890
ABSTRACT
Amyloidotic cardiomyopathy (ACMP) occurs in the setting of rare genetic diseases, blood dyscrasias, chronic infection and inflammation, and advanced age. Cardiologists are on the front lines of diagnosis of ACMP when evaluating patients with unexplained dyspnea, congestive heart failure, or arrhythmias. Noninvasive detection of diastolic cardiac dysfunction and unexplained left ventricular hypertrophy should be followed by biopsy to demonstrate the presence of amyloid deposits and appropriate genetic, biochemical, and immunologic testing to accurately define the type of amyloid. Growing numbers of treatment options exist for these diseases, and timely diagnosis and institution of therapy is essential for preservation of cardiac function.
Texto completo:
1
Banco de datos:
MEDLINE
Asunto principal:
Función Ventricular Izquierda
/
Amiloide
/
Amiloidosis
/
Cardiomiopatías
/
Miocardio
Tipo de estudio:
Diagnostic_studies
/
Etiology_studies
Límite:
Humans
Idioma:
En
Año:
2011
Tipo del documento:
Article